Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases

British Journal of Haematology

Volumn 159, Issue 2, 2012, Pages 164-171

  Montalbán, Carlos ^a   Abraira, Víctor ^a,b   Arcaini, Luca ^c   Domingo Domenech, Eva ^d   Guisado Vasco, Pablo ^a   Iannito, Emilio ^e   Mollejo, Manuela ^f   Matutes, Estella ^g   Ferreri, Andrés ^h   Salar, Antonio ⁱ   Rattotti, Sara ^c   Carpaneto, Andrea ^j   Pérez Fernández, Ricardo ^k   Bello, José L ^l   Hernández, Miguel ^m   Caballero, Dolores ⁿ   Carbonell, Felix ^o   Piris, Miguel A ^p  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF PAVIA   (Italy)

^d HOSPITAL DURAN I REYNALS   (Spain)

^e SG Moscati Hospital   (Italy)

^f HOSPITAL VIRGEN DE LA SALUD   (Spain)

^g ROYAL MARSDEN HOSPITAL   (United Kingdom)

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ HOSPITAL DEL MAR   (Spain)

^j UOC Ematologia Ospedale Sant'Anna   (Italy)

^k HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^l Instituto de Salud Carlos III   (Spain)

^m HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

ⁿ HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^o HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^p HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

more..

Author keywords

Clinical studies; Lymphoid malignancies; Lymphoma; Lymphoproliferative disease; Non hodgkin lymphoma

Indexed keywords

HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN DETERMINATION; HEPATITIS C; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SPLENIC MARGINAL ZONE LYMPHOMA; THROMBOCYTE COUNT; VALIDATION STUDY;

AGED; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBINS; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; RISK FACTORS; SPLENIC NEOPLASMS; SURVIVAL RATE;

EID: 84866875619     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12011     Document Type: Article

References (18)

1. Altman, D.G., Vergouwe, Y., Royston, P. & Moons, K.G. (2009) Prognosis and prognostic research: validating a prognostic model. British Medical Journal, 338, b605.
2. Arcaini, L., Paulli, M., Boveri, E., Vallisa, D., Bernuzzi, P., Orlandi, E., Incardona, P., Brusamolino, E., Passamonti, F., Burcheri, S., Schena, C., Pascutto, C., Cavanna, L., Magrini, U. & Lazzarino, M. (2004) Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer, 100, 107-115.
3. Arcaini, L., Lazzarino, M., Colombo, N., Burcheri, S., Boveri, E., Paulli, M., Morra, E., Gambacorta, M., Cortelazzo, S., Tucci, A., Ungari, M., Ambrosetti, A., Menestrina, F., Orsucci, L., Novero, D., Pulsoni, A., Frezzato, M., Gaidano, G., Vallisa, D., Minardi, V., Tripodo, C., Callea, V., Baldini, L., Merli, F., Federico, M., Franco, V. & Iannito, E., Intergruppo Italiano Linfomi. (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood, 107, 4643-4649.
4. Chacon, J., Mollejo, M., Muñoz, E., Algara, P., Mateo, M., López, L., Andrade, J., Carbonero, J.G., Martínez, B., Piris, M.A. & Cruz, M.A. (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood, 100, 1648-1654.
5. Cook, N.R. & Ridker, P.M. (2009) Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Annals of Internal Medicine, 150, 795-802.
6. Hosmer, D.W. & Lemeshow, S. (1999) Applied Survival Analysis: Regression Modeling of Time to Event Data. John Wiley & Sons, New York.
7. Kanellis, G., Mollejo, M., Montes-Moreno, S., Rodríguez-Pinilla, S.M., Cigudosa, J.C., Algara, P., Montalban, C., Matutes, E., Wotherspoon, A. & Piris, M.A. (2010) Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica, 95, 1122-1129.
8. Matutes, E., Oscier, D., Montalban, C., Berger, F., Callet-Bauchu, E., Dogan, A., Felman, P., Franco, V., Iannitto, E., Mollejo, M., Papadaki, T., Remstein, E.D., Salar, A., Solé, F., Stamatopoulos, K., Thieblemont, C., Traverse-Glehen, A., Wotherspoon, A., Coiffier, B. & Piris, M.A. (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia, 22, 487-495.
9. Parry-Jones, N., Matutes, E., Gruszka-Westwood, A.M., Swansbury, G.J., Wotherspoon, A.C. & Catovsky, D. (2003) Prognostic features of splenic lymphoma with villous lymphocytes: a report of 129 patients. British Journal Haematology, 120, 759-764.
10. Pencina, M.J., D'Agostino, Sr, R.B. & Steyerberg, E.W. (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Statistics in Medicine, 30, 11-21.
11. Royston, P. & Sauerbrei, W. (2008) Multivariable Model-Building. A Pragmatic Approach Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables. John Wiley & Sons, Chichester.
12. Royston, P., Altman, D.G. & Sauerbrei, W. (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Statistics in Medicine, 25, 127-141.
13. Ruiz Ballesteros, E., Mollejo, M., Rodriguez, A., Camacho, F.I., Algara, P., Martinez, N., Pollán, M., Sanchez-Aguilera, A., Menarguez, J., Campo, E., Martinez, P., Mateo, M. & Piris, M.A. (2005) Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. Blood, 106, 1831-1838.
14. Salido, M., Baro, C., Oscier, D., Stamatopoulos, K., Dierlamm, J., Matutes, E., Traverse-Glehen, A., Berger, F., Felman, P., Thieblemont, C., Gesk, S., Athanasiadou, A., Davis, Z., Gardiner, A., Milla, F., Ferrer, A., Mollejo, M., Calasanz, M.J., Florensa, L., Espinet, B., Luño, E., Wlodarska, I., Verhoef, G., García-Granero, M., Salar, A., Papadaki, T., Serrano, S., Piris, M.A. & Solé, F. (2010) Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal lymphomas: a multicenter study of the Splenic B-cell Lymphoma Group. Blood, 116, 1479-1488.
15. Swerdlow, S.H., Campos, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) Pathology and genetics of tumors of hematopoietic and lymphoid tissues. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press, Lyon.
16. Thieblemont, C., Felman, P., Berger, F., Dumontet, C., Arnaud, P., Hequet, O., Arcache, J., Callet-Bauchu, E., Salles, G. & Coiffier, B. (2002) Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clinical Lymphoma, Myeloma & Leukemia, 3, 41-47.
17. Traverse-Glehen, A., Baseggio, L., Callet-Bauchu, E., Morel, D., Gazzo, S., Ffrench, M., Verney, A., Rolland, D., Thieblemont, C., Magaud, J.P., Salles, G., Coiffier, B., Berger, F. & Felman, P. (2008) Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathological and molecular entity? Blood, 111, 2253-2260.
18. Troussard, X., Valensi, F., Duchayne, E., Garand, R., Felman, P., Tulliez, M., Henry-Amar, M., Bryon, P.A. & Flandrin, G. (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC). British Journal Haematology, 93, 731-736.